Medical Care

Global Plasma Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

In 2024, the global market size of Plasma Therapy was estimated to be worth US$ 328 million and is forecast to reach approximately US$ 633 million by 2031 with a CAGR of 10.0% during the forecast period 2025-2031.
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
North America is the largest consumption place, with a consumption market share nearly 53% . Europe is the second largest consumption place with the consumption market share of 26%. Terumo, Arthrex, Zimmer Biomet, DePuy Synthes and EmCyte are the leaders of the industry, top 3 companies occupied about 55% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Therapy.
The Plasma Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plasma Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics
Segment by Type
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
Segment by Application
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Plasma Therapy in global and regional level.
Chapter 3: Detailed analysis of Plasma Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma Therapy revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Plasma Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Plasma Therapy Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Pure PRP
1.2.3 Leucocyte-rich PRP
1.2.4 Leukocyte-rich Fibrin (L-PRF)
1.3 Market by Application
1.3.1 Global Plasma Therapy Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Orthopedic
1.3.3 Darmatology
1.3.4 Cardiac Muscle Injury
1.3.5 Dental
1.3.6 Nerve Injury
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Plasma Therapy Market Size Estimates and Forecasts
2.2 Plasma Therapy Market Size by Region: 2024 Versus 2031
2.2.1 Global Plasma Therapy Revenue by Region: 2020-2025
2.2.2 Global Plasma Therapy Revenue Forecast by Region (2026-2031)
2.2.3 Global Plasma Therapy Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Plasma Therapy Revenue by Type (2020-2031)
3.1.2 Global Plasma Therapy Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Plasma Therapy Revenue by Application (2020-2031)
3.2.2 Global Plasma Therapy Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Pure PRP of Plasma Therapy Revenue Market Share by Application
3.3.2 Leucocyte-rich PRP of Plasma Therapy Revenue Market Share by Application
3.3.3 Leukocyte-rich Fibrin (L-PRF) of Plasma Therapy Revenue Market Share by Application
4 Global Plasma Therapy by Company
4.1 Global Plasma Therapy Revenue by Company (2020-2025)
4.2 Global Plasma Therapy Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Plasma Therapy Companies around the World: Ranking by Revenue
4.3.2 Global Plasma Therapy Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Plasma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Plasma Therapy Companies Headquarters & Product Type
4.4.1 Global Plasma Therapy Companies Headquarters
4.4.2 Date of International Companies Enter into Plasma Therapy Market
4.4.3 Global Plasma Therapy Companies Product & Service
4.4.4 Pure PRP Revenue Market Share of Plasma Therapy by Company
4.4.5 Leucocyte-rich PRP Revenue Market Share of Plasma Therapy by Company
4.4.6 Leukocyte-rich Fibrin (L-PRF) Revenue Market Share of Plasma Therapy by Company
4.5 Global Plasma Therapy Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Terumo
5.1.1 Terumo Corporation Information
5.1.2 Terumo Description, Business Overview
5.1.3 Terumo Plasma Therapy Products Offered
5.1.4 Terumo Plasma Therapy Revenue and Gross Margin (2020-2025)
5.1.5 Terumo Plasma Therapy Revenue by Product in 2024
5.1.6 Terumo Plasma Therapy Revenue by Application in 2024
5.1.7 Terumo Plasma Therapy Revenue by Geographic Area in 2024
5.1.8 Terumo Recent Developments
5.2 Arthrex
5.2.1 Arthrex Corporation Information
5.2.2 Arthrex Description, Business Overview
5.2.3 Arthrex Plasma Therapy Products Offered
5.2.4 Arthrex Plasma Therapy Revenue and Gross Margin (2020-2025)
5.2.5 Arthrex Plasma Therapy Revenue by Product in 2024
5.2.6 Arthrex Plasma Therapy Revenue by Application in 2024
5.2.7 Arthrex Plasma Therapy Revenue by Geographic Area in 2024
5.2.8 Arthrex Recent Developments
5.3 Zimmer Biomet
5.3.1 Zimmer Biomet Corporation Information
5.3.2 Zimmer Biomet Description, Business Overview
5.3.3 Zimmer Biomet Plasma Therapy Products Offered
5.3.4 Zimmer Biomet Plasma Therapy Revenue and Gross Margin (2020-2025)
5.3.5 Zimmer Biomet Plasma Therapy Revenue by Product in 2024
5.3.6 Zimmer Biomet Plasma Therapy Revenue by Application in 2024
5.3.7 Zimmer Biomet Plasma Therapy Revenue by Geographic Area in 2024
5.3.8 Zimmer Biomet Recent Developments
5.4 DePuy Synthes
5.4.1 DePuy Synthes Corporation Information
5.4.2 DePuy Synthes Description, Business Overview
5.4.3 DePuy Synthes Plasma Therapy Products Offered
5.4.4 DePuy Synthes Plasma Therapy Revenue and Gross Margin (2020-2025)
5.4.5 DePuy Synthes Plasma Therapy Revenue by Product in 2024
5.4.6 DePuy Synthes Plasma Therapy Revenue by Application in 2024
5.4.7 DePuy Synthes Plasma Therapy Revenue by Geographic Area in 2024
5.4.8 DePuy Synthes Recent Developments
5.5 EmCyte
5.5.1 EmCyte Corporation Information
5.5.2 EmCyte Description, Business Overview
5.5.3 EmCyte Plasma Therapy Products Offered
5.5.4 EmCyte Plasma Therapy Revenue and Gross Margin (2020-2025)
5.5.5 EmCyte Plasma Therapy Revenue by Product in 2024
5.5.6 EmCyte Plasma Therapy Revenue by Application in 2024
5.5.7 EmCyte Plasma Therapy Revenue by Geographic Area in 2024
5.5.8 EmCyte Recent Developments
5.6 Regen Lab
5.6.1 Regen Lab Corporation Information
5.6.2 Regen Lab Description, Business Overview
5.6.3 Regen Lab Plasma Therapy Products Offered
5.6.4 Regen Lab Plasma Therapy Revenue and Gross Margin (2020-2025)
5.6.5 Regen Lab Plasma Therapy Revenue by Product in 2024
5.6.6 Regen Lab Plasma Therapy Revenue by Application in 2024
5.6.7 Regen Lab Plasma Therapy Revenue by Geographic Area in 2024
5.6.8 Regen Lab Recent Developments
5.7 ISTO Biologics
5.7.1 ISTO Biologics Corporation Information
5.7.2 ISTO Biologics Description, Business Overview
5.7.3 ISTO Biologics Plasma Therapy Products Offered
5.7.4 ISTO Biologics Plasma Therapy Revenue and Gross Margin (2020-2025)
5.7.5 ISTO Biologics Plasma Therapy Revenue by Product in 2024
5.7.6 ISTO Biologics Plasma Therapy Revenue by Application in 2024
5.7.7 ISTO Biologics Plasma Therapy Revenue by Geographic Area in 2024
5.7.8 ISTO Biologics Recent Developments
5.8 Cesca Therapeutics
5.8.1 Cesca Therapeutics Corporation Information
5.8.2 Cesca Therapeutics Description, Business Overview
5.8.3 Cesca Therapeutics Plasma Therapy Products Offered
5.8.4 Cesca Therapeutics Plasma Therapy Revenue and Gross Margin (2020-2025)
5.8.5 Cesca Therapeutics Plasma Therapy Revenue by Product in 2024
5.8.6 Cesca Therapeutics Plasma Therapy Revenue by Application in 2024
5.8.7 Cesca Therapeutics Plasma Therapy Revenue by Geographic Area in 2024
5.8.8 Cesca Therapeutics Recent Developments
5.9 Weigao
5.9.1 Weigao Corporation Information
5.9.2 Weigao Description, Business Overview
5.9.3 Weigao Plasma Therapy Products Offered
5.9.4 Weigao Plasma Therapy Revenue and Gross Margin (2020-2025)
5.9.5 Weigao Plasma Therapy Revenue by Product in 2024
5.9.6 Weigao Plasma Therapy Revenue by Application in 2024
5.9.7 Weigao Plasma Therapy Revenue by Geographic Area in 2024
5.9.8 Weigao Recent Developments
5.10 REV-MED
5.10.1 REV-MED Corporation Information
5.10.2 REV-MED Description, Business Overview
5.10.3 REV-MED Plasma Therapy Products Offered
5.10.4 REV-MED Plasma Therapy Revenue and Gross Margin (2020-2025)
5.10.5 REV-MED Plasma Therapy Revenue by Product in 2024
5.10.6 REV-MED Plasma Therapy Revenue by Application in 2024
5.10.7 REV-MED Plasma Therapy Revenue by Geographic Area in 2024
5.10.8 REV-MED Recent Developments
5.11 Nuo Therapeutics
5.11.1 Nuo Therapeutics Corporation Information
5.11.2 Nuo Therapeutics Description, Business Overview
5.11.3 Nuo Therapeutics Plasma Therapy Products Offered
5.11.4 Nuo Therapeutics Plasma Therapy Revenue and Gross Margin (2020-2025)
5.11.5 Nuo Therapeutics Plasma Therapy Revenue by Product in 2024
5.11.6 Nuo Therapeutics Plasma Therapy Revenue by Application in 2024
5.11.7 Nuo Therapeutics Plasma Therapy Revenue by Geographic Area in 2024
5.11.8 Nuo Therapeutics Recent Developments
6 North America
6.1 North America Plasma Therapy Market Size YoY Growth 2020-2031
6.2 North America Plasma Therapy Market Facts & Figures by Country (2020-2031)
6.3 North America Plasma Therapy Revenue by Type (2020-2025)
6.4 North America Plasma Therapy Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Plasma Therapy Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Plasma Therapy Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Plasma Therapy Revenue by Type (2020-2025)
7.4 Asia-Pacific Plasma Therapy Revenue by Application (2020-2025)
8 Europe
8.1 Europe Plasma Therapy Market Size YoY Growth 2020-2031
8.2 Europe Plasma Therapy Market Facts & Figures by Country (2020-2031)
8.3 Europe Plasma Therapy Revenue by Type (2020-2025)
8.4 Europe Plasma Therapy Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Plasma Therapy Market Size YoY Growth 2020-2031
9.2 Latin America Plasma Therapy Market Facts & Figures by Country (2020-2031)
9.3 Latin America Plasma Therapy Revenue by Type (2020-2025)
9.4 Latin America Plasma Therapy Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Plasma Therapy Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Plasma Therapy Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Plasma Therapy Revenue by Type (2020-2025)
10.4 Middle East and Africa Plasma Therapy Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Plasma Therapy Supply Chain Analysis
11.2 Plasma Therapy Key Raw Materials and Upstream Suppliers
11.3 Plasma Therapy Clients Analysis
11.4 Plasma Therapy Sales Channel and Sales Model Analysis
11.4.1 Plasma Therapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Plasma Therapy Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Plasma Therapy Distributors
12 Plasma Therapy Market Dynamics
12.1 Plasma Therapy Industry Trends
12.2 Plasma Therapy Market Drivers
12.3 Plasma Therapy Market Challenges
12.4 Plasma Therapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Plasma Therapy Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Plasma Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Plasma Therapy Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Plasma Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Plasma Therapy Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Plasma Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Plasma Therapy Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Plasma Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Plasma Therapy Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Plasma Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 11. Plasma Therapy Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Plasma Therapy Players by Revenue (US$ Million) in 2024
Table 13. Global Plasma Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Plasma Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Therapy as of 2024)
Table 15. Global Plasma Therapy Companies Headquarters
Table 16. Date of International Companies Enter into Plasma Therapy Market
Table 17. Global Plasma Therapy Companies Product & Service
Table 18. Global Plasma Therapy Mergers & Acquisitions, Expansion Plans
Table 19. Terumo Corporation Information
Table 20. Terumo Description and Business Overview
Table 21. Terumo Plasma Therapy Product
Table 22. Terumo Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Terumo Revenue Proportion of Plasma Therapy by Product in 2024
Table 24. Terumo Revenue Proportion of Plasma Therapy by Application in 2024
Table 25. Terumo Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 26. Terumo Recent Developments
Table 27. Arthrex Corporation Information
Table 28. Arthrex Description and Business Overview
Table 29. Arthrex Plasma Therapy Product
Table 30. Arthrex Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Arthrex Revenue Proportion of Plasma Therapy by Product in 2024
Table 32. Arthrex Revenue Proportion of Plasma Therapy by Application in 2024
Table 33. Arthrex Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 34. Arthrex Recent Developments
Table 35. Zimmer Biomet Corporation Information
Table 36. Zimmer Biomet Description and Business Overview
Table 37. Zimmer Biomet Plasma Therapy Product
Table 38. Zimmer Biomet Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Zimmer Biomet Revenue Proportion of Plasma Therapy by Product in 2024
Table 40. Zimmer Biomet Revenue Proportion of Plasma Therapy by Application in 2024
Table 41. Zimmer Biomet Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 42. Zimmer Biomet Recent Developments
Table 43. DePuy Synthes Corporation Information
Table 44. DePuy Synthes Description and Business Overview
Table 45. DePuy Synthes Plasma Therapy Product
Table 46. DePuy Synthes Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. DePuy Synthes Revenue Proportion of Plasma Therapy by Product in 2024
Table 48. DePuy Synthes Revenue Proportion of Plasma Therapy by Application in 2024
Table 49. DePuy Synthes Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 50. DePuy Synthes Recent Developments
Table 51. EmCyte Corporation Information
Table 52. EmCyte Description and Business Overview
Table 53. EmCyte Plasma Therapy Product
Table 54. EmCyte Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. EmCyte Revenue Proportion of Plasma Therapy by Product in 2024
Table 56. EmCyte Revenue Proportion of Plasma Therapy by Application in 2024
Table 57. EmCyte Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 58. EmCyte Recent Developments
Table 59. Regen Lab Corporation Information
Table 60. Regen Lab Description and Business Overview
Table 61. Regen Lab Plasma Therapy Product
Table 62. Regen Lab Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Regen Lab Revenue Proportion of Plasma Therapy by Product in 2024
Table 64. Regen Lab Revenue Proportion of Plasma Therapy by Application in 2024
Table 65. Regen Lab Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 66. Regen Lab Recent Developments
Table 67. ISTO Biologics Corporation Information
Table 68. ISTO Biologics Description and Business Overview
Table 69. ISTO Biologics Plasma Therapy Product
Table 70. ISTO Biologics Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. ISTO Biologics Revenue Proportion of Plasma Therapy by Product in 2024
Table 72. ISTO Biologics Revenue Proportion of Plasma Therapy by Application in 2024
Table 73. ISTO Biologics Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 74. ISTO Biologics Recent Developments
Table 75. Cesca Therapeutics Corporation Information
Table 76. Cesca Therapeutics Description and Business Overview
Table 77. Cesca Therapeutics Plasma Therapy Product
Table 78. Cesca Therapeutics Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Cesca Therapeutics Revenue Proportion of Plasma Therapy by Product in 2024
Table 80. Cesca Therapeutics Revenue Proportion of Plasma Therapy by Application in 2024
Table 81. Cesca Therapeutics Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 82. Cesca Therapeutics Recent Developments
Table 83. Weigao Corporation Information
Table 84. Weigao Description and Business Overview
Table 85. Weigao Plasma Therapy Product
Table 86. Weigao Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Weigao Revenue Proportion of Plasma Therapy by Product in 2024
Table 88. Weigao Revenue Proportion of Plasma Therapy by Application in 2024
Table 89. Weigao Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 90. Weigao Recent Developments
Table 91. REV-MED Corporation Information
Table 92. REV-MED Description and Business Overview
Table 93. REV-MED Plasma Therapy Product
Table 94. REV-MED Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. REV-MED Revenue Proportion of Plasma Therapy by Product in 2024
Table 96. REV-MED Revenue Proportion of Plasma Therapy by Application in 2024
Table 97. REV-MED Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 98. REV-MED Recent Developments
Table 99. Nuo Therapeutics Corporation Information
Table 100. Nuo Therapeutics Description and Business Overview
Table 101. Nuo Therapeutics Plasma Therapy Product
Table 102. Nuo Therapeutics Plasma Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Nuo Therapeutics Revenue Proportion of Plasma Therapy by Product in 2024
Table 104. Nuo Therapeutics Revenue Proportion of Plasma Therapy by Application in 2024
Table 105. Nuo Therapeutics Revenue Proportion of Plasma Therapy by Geographic Area in 2024
Table 106. Nuo Therapeutics Recent Developments
Table 107. North America Plasma Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 108. North America Plasma Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 109. North America Plasma Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 110. North America Plasma Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 111. Asia-Pacific Plasma Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 112. Asia-Pacific Plasma Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 113. Asia-Pacific Plasma Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 114. Asia-Pacific Plasma Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 115. Europe Plasma Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 116. Europe Plasma Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 117. Europe Plasma Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 118. Europe Plasma Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 119. Latin America Plasma Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 120. Latin America Plasma Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 121. Latin America Plasma Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 122. Latin America Plasma Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 123. Middle East and Africa Plasma Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 124. Middle East and Africa Plasma Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 125. Middle East and Africa Plasma Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 126. Middle East and Africa Plasma Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 127. Plasma Therapy Key Raw Materials, Industry Status and Trend
Table 128. Plasma Therapy Key Raw Materials and Upstream Suppliers
Table 129. Plasma Therapy Clients Status and Trend
Table 130. Plasma Therapy Typical Clients
Table 131. Plasma Therapy Distributors
Table 132. Plasma Therapy Market Trends
Table 133. Plasma Therapy Market Drivers
Table 134. Plasma Therapy Market Challenges
Table 135. Plasma Therapy Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources


List of Figures
Figure 1. Plasma Therapy Product Picture
Figure 2. Global Plasma Therapy Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Plasma Therapy Revenue Market Share by Type in 2024 & 2031
Figure 4. Pure PRP Product Picture
Figure 5. Leucocyte-rich PRP Product Picture
Figure 6. Leukocyte-rich Fibrin (L-PRF) Product Picture
Figure 7. Global Plasma Therapy Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Plasma Therapy Revenue Market Share by Application in 2024 & 2031
Figure 9. Orthopedic
Figure 10. Darmatology
Figure 11. Cardiac Muscle Injury
Figure 12. Dental
Figure 13. Nerve Injury
Figure 14. Plasma Therapy Report Years Considered
Figure 15. Global Plasma Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Plasma Therapy Market Size (2020-2031) & (US$ Million)
Figure 17. Global Plasma Therapy Market Size Market Share by Region: 2024 Versus 2031
Figure 18. Global Plasma Therapy Revenue Market Share by Region (2020-2031)
Figure 19. Global Plasma Therapy Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Global Plasma Therapy Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Pure PRP of Plasma Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 22. Leucocyte-rich PRP of Plasma Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 23. Leukocyte-rich Fibrin (L-PRF) of Plasma Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 24. Plasma Therapy Revenue Share by Company (2024)
Figure 25. Plasma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Pure PRP Revenue Proportion by Company in 2024
Figure 27. Leucocyte-rich PRP Revenue Proportion by Company in 2024
Figure 28. Leukocyte-rich Fibrin (L-PRF) Revenue Proportion by Company in 2024
Figure 29. North America Plasma Therapy Revenue 2020-2031 (US$ Million)
Figure 30. North America Plasma Therapy Revenue Market Share by Type (2020-2025)
Figure 31. North America Plasma Therapy Revenue Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Plasma Therapy Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Plasma Therapy Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Plasma Therapy Revenue Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Plasma Therapy Revenue Market Share by Application (2020-2025)
Figure 36. Europe Plasma Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Plasma Therapy Revenue Market Share by Country (2020-2031)
Figure 38. Europe Plasma Therapy Revenue Market Share by Type (2020-2025)
Figure 39. Europe Plasma Therapy Revenue Market Share by Application (2020-2025)
Figure 40. Latin America Plasma Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Latin America Plasma Therapy Revenue Market Share by Country (2020-2031)
Figure 42. Latin America Plasma Therapy Revenue Market Share by Type (2020-2025)
Figure 43. Latin America Plasma Therapy Revenue Market Share by Application (2020-2025)
Figure 44. Middle East and Africa Plasma Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Middle East and Africa Plasma Therapy Revenue Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Plasma Therapy Revenue Market Share by Type (2020-2025)
Figure 47. Middle East and Africa Plasma Therapy Revenue Market Share by Application (2020-2025)
Figure 48. Plasma Therapy Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Plasma Therapy Raw Materials by Region in 2024
Figure 50. Plasma Therapy Distribution Channels
Figure 51. Global Plasma Therapy Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 52. Global Plasma Therapy Percentage 2020-2031: Online Sales VS Offline Sales
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies